Design and Therapeutic Potential of Peptides
- 1 January 1991
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Characterization of the human immunodeficiency virus type-1 reverse transcriptase enzyme produced in yeastBiochemical and Biophysical Research Communications, 1990
- Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agaroseBiochemical and Biophysical Research Communications, 1990
- Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinasesBiochemical and Biophysical Research Communications, 1990
- Potent and prolonged melanotropic activities of the α-MSH fragment analog, Ac-[Nle4, D-Phe7]-α-MSH4–9-NH2Biochemical and Biophysical Research Communications, 1986
- Substance K and substance P as possible endogenous substrates of angiotensin converting enzyme in the brainBiochemical and Biophysical Research Communications, 1985
- Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: A new highly potent and fully specific agonist for opiate δ-receptorsBiochemical and Biophysical Research Communications, 1983
- Cyclic enkephalin analogs containing a cystine bridgeBiochemical and Biophysical Research Communications, 1981
- Tetrapeptide-amide analogues of enkephalin: The role of C-terminus in determining the character of opioid activityBiochemical and Biophysical Research Communications, 1979
- D-Ala2, ΔzPhe4-methionine enkephalin amide, a dehydropeptide hormoneBiochemical and Biophysical Research Communications, 1978
- Enzymic degradation of luteinizing hormone-releasing hormone (LH-RH) by hypothalamic tissueBiochemical and Biophysical Research Communications, 1974